Working capacity is increased following recombinant human erythropoietin treatment
- PMID: 3199672
- DOI: 10.1038/ki.1988.213
Working capacity is increased following recombinant human erythropoietin treatment
Abstract
To investigate the effect of partial correction of anemia in patients maintained by chronic intermittent hemodialysis on aerobic and anaerobic working capacity, eight patients underwent a bicycle spiro-ergometry before and after treatment with recombinant human erythropoietin (r-HuEPO). the initial mean (+/- SD) hemoglobin value was 5.9 mg/dl +/- 0.61 and increased during treatment to 10.9 +/- 0.59 mg/dl, P less than 0.0001). This partial correction of anemia resulted in a significant increase of both oxygen uptake at the anaerobic threshold and peak peripheral oxygen uptake at subjective exhaustion (P less than 0.01 and P less than 0.0002, respectively). The increase in oxygen uptake corresponded to significant increases in Watts, both at the anaerobic threshold and at maximum workload (P less than 0.02 and P less than 0.0004). These data show that partial correction of renal anemia results in a significant increase of both exercise capacity and maximum work.
Similar articles
-
[Aerobic and anaerobic capacity of chronic hemodialysis patients under continuous therapy with recombinant human erythropoietin].Nephron. 1989;51 Suppl 1:34-8. doi: 10.1159/000185569. Nephron. 1989. PMID: 2915781 German.
-
Effects of recombinant human erythropoietin and exercise training on exercise capacity in hemodialysis patients.Artif Organs. 1995 Dec;19(12):1262-8. doi: 10.1111/j.1525-1594.1995.tb02297.x. Artif Organs. 1995. PMID: 8967886
-
Mechanisms of improved physical performance of chronic hemodialysis patients after erythropoietin treatment.Am J Nephrol. 1990;10 Suppl 2:15-8; discussion 18-23. doi: 10.1159/000168211. Am J Nephrol. 1990. PMID: 2124412
-
Clinical efficacy of recombinant human erythropoietin in hemodialysis patients.Semin Nephrol. 1989 Mar;9(1 Suppl 1):16-21. Semin Nephrol. 1989. PMID: 2648516 Review.
-
Optimal haemoglobin during treatment with recombinant human erythropoietin.Nephrol Dial Transplant. 1998;13 Suppl 2:16-22. doi: 10.1093/ndt/13.suppl_2.16. Nephrol Dial Transplant. 1998. PMID: 9566486 Review.
Cited by
-
Epoetin (recombinant human erythropoietin). A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in anaemia and the stimulation of erythropoiesis.Drugs. 1989 Dec;38(6):863-99. doi: 10.2165/00003495-198938060-00004. Drugs. 1989. PMID: 2693045 Review.
-
A Systematic Method to Detect the Metabolic Threshold from Gas Exchange during Incremental Exercise.J Sports Sci Med. 2017 Aug 8;16(3):396-406. eCollection 2017 Sep. J Sports Sci Med. 2017. PMID: 28912658 Free PMC article.
-
Would artificial neural networks implemented in clinical wards help nephrologists in predicting epoetin responsiveness?BMC Nephrol. 2006 Sep 18;7:13. doi: 10.1186/1471-2369-7-13. BMC Nephrol. 2006. PMID: 16981983 Free PMC article.
-
Quality of life in predialytic uremic patients.Qual Life Res. 1996 Feb;5(1):109-16. doi: 10.1007/BF00435975. Qual Life Res. 1996. PMID: 8901373
-
Central and peripheral adaptations to physical training in patients with end-stage renal disease.Sports Med. 2001;31(9):651-65. doi: 10.2165/00007256-200131090-00002. Sports Med. 2001. PMID: 11508521 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical